Fmoc-L-phenylalaninol

Fmoc-L-phenylalaninol is an N-(9H-fluoren-9-ylmethoxycarbonyl) protected L-phenylalaninol amino alcohol, featuring an Fmoc-protected nitrogen alongside a primary alcohol at the side-chain terminus and a stereogenic center consistent with L-phenylalaninol. The molecule contains an aromatic phenyl ring that supports hydrophobic and π-interaction patterns in peptide-like constructs, while the hydroxymethyl functionality provides a handle for esterification, ether formation, oxidation to carbonyl derivatives, and controlled derivatization. The Fmoc carbamate is stable under many coupling conditions yet can be removed under standard base-mediated deprotection strategies used in solid-phase peptide synthesis, enabling predictable N-terminal incorporation. As a chiral amino alcohol derivative, Fmoc-L-phenylalaninol functions as a protected building block and synthetic intermediate for constructing peptide analogs, chiral scaffolds, and downstream functionalized intermediates.

1. Peptide Synthesis

Fmoc-L-phenylalaninol is applied in peptide synthesis workflows where amino alcohol side chains are required to generate peptidomimetics, cyclic precursors, or modified backbone linkers. The Fmoc-protected amine supports standard peptide coupling chemistry after deprotection, while the hydroxymethyl group can be left intact for hydrogen-bonding interactions or transformed into protected esters/ethers to control chemoselectivity during chain assembly. Incorporation of this chiral phenylalaninol unit can enable formation of peptide analogs that retain stereochemical fidelity at the side-chain carbon bearing the alcohol. Downstream, the resulting sequences can serve as substrates for further functionalization, cyclization, or conjugation steps in peptide science and synthetic methodology development.

2. Peptidomimetics And SAR Studies

Fmoc-L-phenylalaninol is used in peptidomimetic construction and structure-activity relationship studies where side-chain hydroxymethyl groups modulate binding motifs and conformational preferences. The presence of an L-configured stereocenter and a phenyl ring allows the building block to mimic key spatial features of phenylalanine-derived pharmacophores while introducing an alcohol that can participate in hydrogen bonding or be oxidized to a carbonyl for additional interaction modes. Fmoc protection enables controlled N-terminus handling, supporting stepwise synthesis of analog libraries with consistent stereochemistry. Resulting peptide-like scaffolds can be diversified through side-chain derivatization to generate structure-defined analog sets for SAR investigations and molecular recognition studies.

3. Side-Chain Functionalization

Fmoc-L-phenylalaninol is suitable for side-chain functionalization strategies in synthetic organic chemistry and chemical biology research intermediate preparation. The primary alcohol provides a direct site for conversion to esters, carbamates, ethers, or oxidized derivatives, allowing tuning of polarity, reactivity, and compatibility with subsequent coupling steps. Fmoc as an orthogonal protecting group for the amine supports selective transformations at the alcohol while maintaining the nitrogen protected until peptide coupling or deprotection is desired. Functionalized derivatives derived from the phenylalaninol alcohol can be used to access chiral linkers, cyclization precursors, or stereodefined intermediates that feed into larger molecular assemblies.

4. Bioconjugation Chemistry

Fmoc-L-phenylalaninol is applied in bioconjugation chemistry where chiral amino alcohol motifs can be incorporated into linkers or peptide-derived conjugates for controlled labeling and biomolecule modification. The Fmoc-protected nitrogen enables clean downstream deprotection to generate a reactive amine for coupling to activated carboxylates or electrophiles, while the hydroxymethyl group can be converted to handles such as ester- or ether-based functionalities depending on the conjugation strategy. The stereochemical definition of the L-phenylalaninol unit can influence linker geometry and local microenvironment around the conjugation site. Conjugation-ready intermediates produced from this compound can support preparation of labeled peptides, functional probes, and biomolecule-modifying reagents used in biochemical research and analytical development.

5. Chiral Building Block Synthesis

Fmoc-L-phenylalaninol is utilized as a chiral amino acid derivative building block for enantioselective synthesis planning and stereodefined intermediate generation. The protected amine and chiral center enable incorporation into larger frameworks while maintaining the L-configuration through multi-step sequences, including N-deprotection and subsequent coupling or derivatization. The alcohol functionality supports conversion to carbonyl-containing chiral intermediates or protected derivatives that can act as precursors for heterocycle formation and other scaffold elaborations. Downstream, this compound can serve as a practical chiral starting material for producing stereochemically controlled amino alcohol motifs found in peptide analogs, chiral ligands, and industrially relevant fine chemical intermediates.

6. Process Chemistry Intermediate

Fmoc-L-phenylalaninol is relevant to process chemistry and specialty chemical production as a protected amino alcohol intermediate that can be integrated into scalable synthesis routes for peptide-building-block supply chains. The Fmoc carbamate provides a stable nitrogen protection strategy compatible with common peptide coupling and purification steps, while the primary alcohol offers a predictable functional group for controlled derivatization at defined stages of manufacturing. Chiral retention at the L-configuration supports downstream consistency for producing uniform peptide-like materials and chemically defined intermediates. Industrially, the compound can be employed to manufacture protected amino acid derivatives and chiral linker precursors that feed into fine chemical synthesis, including peptide analog production and functional material intermediate preparation.

1. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

2. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines